NIH-funded research NIH-funded research

Developing a new method to detect cancer biomarkers using nanosensor arrays

Official title: High-throughput, purification-free, and ultrasensitive transmembrane nanosensor arrays for digital counting of microRNA biomarkers of intact exosomes

Funded at Arizona State University-Tempe Campus · NIH-11081702 · Data updated 2026-11-12

This study is testing a new, easy way to check for cancer by using tiny sensors that can find specific markers in small samples of body fluids, so patients can avoid the hassle and risks of surgery for biopsies.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionArizona State University-Tempe Campus
NIH-funded
Lab location1 site (Tempe, United States)
Project startMay 15, 2023
Project endApril 30, 2026
Funding year2025
Award (this year)$220,193
NIH project number5R61CA278558-03
Project IDNIH-11081702 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals undergoing evaluation for cancer or those with a known cancer diagnosis who require monitoring.

Less likely to help

Patients who are not diagnosed with cancer or those who are not undergoing any cancer treatment may not benefit from this research.

What this research studies

This research focuses on creating advanced nanosensor arrays that can detect microRNA biomarkers found in exosomes, which are tiny vesicles released by cells. By using a non-invasive approach, this method aims to provide a quicker and more efficient way to diagnose and monitor cancer without the need for surgical biopsies. The technology is designed to be highly sensitive and specific, allowing for the detection of cancer progression through simple body fluid samples. This could significantly reduce the complications and costs associated with traditional biopsy methods.

Why it matters

Potential benefit: If successful, this research could lead to a revolutionary non-invasive diagnostic tool for cancer detection and monitoring.

How similar studies have gone: Previous research has shown promise in using liquid biopsies for cancer detection, but this approach with nanosensor arrays is relatively novel.

Where this research is happening

  • Arizona State University-Tempe Campus
    Tempe, United States
    Active

Researchers

  • Principal investigator: Yan, Hao — Arizona State University-Tempe Campus
  • Study coordinator: Yan, Hao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.